Uncertainty in tuberculosis clinical decision-making

Tuberculosis is a major infectious disease worldwide, but currently available diagnostics have suboptimal accuracy, particularly in patients unable to expectorate, and are often unavailable at the point-of-care in resource-limited settings. Test/treatment decision are, therefore, often made on clinical grounds. We hypothesized that contextual factors beyond disease probability may influence clinical decisions about when to test and when to treat for tuberculosis. This umbrella review aimed to identify such factors, and to develop a framework for uncertainty in tuberculosis clinical decision-making. Systematic reviews were searched in seven databases (MEDLINE, CINAHL Complete, Embase, Scopus, Cochrane, PROSPERO, Epistemonikos) using predetermined search criteria. Findings were classified as barriers and facilitators for testing or treatment decisions, and thematically analysed based on a multi-level model of uncertainty in health care. We included 27 reviews. Study designs and primary aims were heterogeneous, with seven meta-analyses and three qualitative evidence syntheses. Facilitators for decisions to test included providers’ advanced professional qualification and confidence in tests results, availability of automated diagnostics with quick turnaround times. Common barriers for requesting a diagnostic test included: poor provider tuberculosis knowledge, fear of acquiring tuberculosis through respiratory sampling, scarcity of healthcare resources, and complexity of specimen collection. Facilitators for empiric treatment included patients’ young age, severe sickness, and test inaccessibility. Main barriers to treatment included communication obstacles, providers’ high confidence in negative test results (irrespective of negative predictive value). Multiple sources of uncertainty were identified at the patient, provider, diagnostic test, and healthcare system levels. Complex determinants of uncertainty influenced decision-making. This could result in delayed or missed diagnosis and treatment opportunities. It is important to understand the variability associated with patient-provider clinical encounters and healthcare settings, clinicians’ attitudes, and experiences, as well as diagnostic test characteristics, to improve clinical practices, and allow an impactful introduction of novel diagnostics

CINAHL · Cochrane Library · Family medicine · Health care · Intensive care medicine · MEDLINE · Meta-analysis · Pathology · Psychological intervention · Tuberculosis · Clinical Reasoning and Diagnostic Skills · Healthcare cost, quality, practices · Medicine · Nursing · Tuberculosis Research and Epidemiology

• Usability and acceptability of a novel TB infection diagnostic test among key populations in Mexicali

  Open Access•Amanda Brumwell, Rosa Herrera et al.•PLOS Global Public Health•2025

  Incluir item

• Pico, Picos and SPIDER

  Open Access•Abigail M Methley, Stephen Campbell et al.•BMC Health Services Research•2014

  Incluir item

• A systematic review of delay in the diagnosis and treatment of tuberculosis

  Open Access•Dag Gundersen Storla, Solomon Yimer et al.•BMC Public Health•2008

  Incluir item

• The PRISMA 2020 statement

  Matthew J Page, Joanne Mckenzie et al.•2020

  Incluir item

• Grade

  Open Access•Gordon H Guyatt, Gordon Guaytt et al.•BMJ•2008

  Incluir item

• Summarizing systematic reviews

  Edoardo Aromataris, Ritin Fernandez et al.•International Journal of…•2015

  Incluir item

• Applying GRADE-Cerqual to qualitative evidence synthesis findings

  Open Access•Simon Lewin, Andrew Booth et al.•Implementation Science•2018

  Incluir item

• High-quality health systems in the Sustainable Development Goals era

  Open Access•Margaret E Kruk, Anna D Gage et al.•The Lancet Global Health•2018

  Incluir item

• Developing an integrated multilevel model of uncertainty in health care

  Open Access•Prashanti Eachempati, Roland Brian Büchter et al.•BMJ Global Health•2022

  Incluir item

• How patients navigate the diagnostic ecosystem in a fragmented health system

  Open Access•Vijayashree Yellapa, Narayanan Devadasan et al.•Global Health Action•2017

  Incluir item

• Barriers to initiating tuberculosis treatment in sub-Saharan Africa

  Open Access•Brittney van de Water, B Emily Esmaili et al.•Global Health Action•2017

  Incluir item

• A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria

  Open Access•Charity Oga‐Omenka, Lawrence Wakdet et al.•BMC Public Health•2021

  Incluir item